Mounjaro injection: how much weight loss can you realistically expect each month?

How much weight does the Mounjaro injection typically cause you to lose in the first month?

The honest answer is: not as much as the 72-week headline suggests, and deliberately so. Treatment begins at 2.5mg, a dose whose job is to help your system adjust, not to produce rapid loss. Most people notice appetite changes within the first fortnight, but the scales may move modestly in month one, typically somewhere in the 2–4% body-weight range at most, and often less.

That starting dose exists because the most common side effects of tirzepatide (nausea, indigestion, loose stools) are dose-related and settle as your body adapts. Pushing through too quickly tends to produce more discomfort without more loss. The prescriber, not the patient, makes titration decisions, and that pace is there for good clinical reasons.

Over time, as doses increase toward 5mg, 7.5mg and beyond, the monthly rate tends to rise. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at 15mg over 72 weeks among thousands of adults with obesity. Spreading that evenly gives a rough sense of pace, though loss is rarely linear, and if you want to understand how much weight loss Mounjaro typically delivers at each stage of treatment, our dedicated page covers the trajectory in more detail. Our page on Mounjaro monthly weight loss covers the trajectory in more detail.

Does the monthly result depend on which dose you are taking, and does that affect the price?

Both questions have the same short answer: yes. Tirzepatide is licensed in the UK in six strengths (2.5mg through to 15mg) and the evidence shows a clear dose-response relationship: higher doses, on average, produce greater weight loss. NICE's appraisal of tirzepatide (TA1026) notes the 15mg data as the most clinically significant, which is why the titration schedule exists in the first place.

On pricing: UK private treatment is priced per pen, and each pen covers four weekly doses. Since Eli Lilly raised Mounjaro's UK list price in September 2025 (the highest-dose pen's list price rose from around £122 to around £330) the typical private market range runs from roughly £149 to £375 per month depending on the dose and the provider. Those figures are widely reported and hedged; your specific treatment cost is confirmed at consultation and on our Mounjaro UK price page.

The practical point: your dose will increase over time if you tolerate treatment well, which means your monthly cost may increase too. Any legitimate provider should be transparent about that from the start. A headline introductory price that only shows the starter dose cost is telling half the story.

What does the Mounjaro price actually include, and what often gets left out of cheaper listings?

This is where the numbers diverge most sharply between providers. A legitimate monthly cost for tirzepatide should bundle the consultation, the prescription, the medicine itself, and delivery. Several services charge separately for one or more of those, a consultation fee upfront, a prescription fee on top, or a delivery charge per order. Others price just the medicine and bill separately for clinical support if you need a dose review or encounter a side effect.

At nume, one price covers the lot: your consultation, prescription, the treatment, and free next-working-day delivery. When your order leaves our GPhC-registered pharmacy before 12pm on a weekday, DPD picks it up the same day, you get a tracking link, and the pen arrives in plain, unbranded packaging the following working day. Our Mounjaro discount page explains clearly why we do not offer discount codes or promotional pricing, and what we do offer instead.

We are not the cheapest option in this market, and we made that choice deliberately. What the price buys is a named prescriber reviewing your answers, photo-ID and live weight verification, GP notification in line with GPhC guidance, and aftercare seven days a week. For context on how our pricing sits overall, the full cost breakdown and Mounjaro pricing page are the right places to check current figures.

Why is 'cheapest per month' the wrong question when comparing Mounjaro providers?

For most purchases, price is a reasonable proxy for value. For a prescription medicine that requires clinical assessment, ongoing monitoring, and an unbroken licensed supply chain, it is the wrong test. The MHRA has warned publicly and repeatedly about counterfeit tirzepatide pens, in October 2025, enforcement teams raided the first illicit UK manufacturing site producing fake Mounjaro, and approximately 20 million doses of illegally traded weight-loss medicines (roughly £45m in street value) were seized across 2025 alone. Fake pens have contained insulin and other substances. Report suspect sellers at the MHRA Yellow Card site.

Prices far below the market range, sellers offering treatment without a clinical assessment, and discount codes from unverified accounts are the consistent red flags. A small monthly saving is not worth the risk of a counterfeit injection. You can verify any online pharmacy on the GPhC register, our premises registration number is 9012878.

The right question is whether the provider can demonstrate genuine supply, real clinical oversight, and a process you can verify. That is the standard we are measured against, and it is the one worth applying to every option you consider. When you are ready to see whether Mounjaro is clinically suitable for you, start your free consultation and a prescriber will review it the same day.